Nicholas M. Allen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nicholas M. Allen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Amre Shahwan
Department of Neurology and Clinical Neurophysiology Children’s Health Ireland at Temple Street Dublin Ireland
1 shared publication Bryan Lynch
Department of Neurology and Clinical Neurophysiology Children’s Health Ireland at Temple Street Dublin Ireland
1 shared publication- David Webb
Department of Neurology and Clinical Neurophysiology Children’s Health Ireland at Crumlin Dublin Ireland
1 shared publication Declan O’rOurke
Department of Neurology and Clinical Neurophysiology Children’s Health Ireland at Temple Street Dublin Ireland
1 shared publicationIreti Farombi-Oghuvbu
Department of Neonatology, Rotunda Hospital, Dublin, Ireland
1 shared publicationIrish Paediatric Neurology Group
Members of the Irish Paediatric Neurology Group are listed in the Acknowledgements
1 shared publication
Latest Publications
- Open Access
- 29 January 2022
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 64 (6) , 780-788
Response to treatment and outcomes of infantile spasms in Down syndrome
Aim: To estimate the prevalence, and evaluate presentation, treatment response, treatment side effects, and long‐term seizure outcomes in all known cases of children with Down syndrome and infantile spasms on the island of Ireland.Method: This was a 10‐year retrospective multicentre review of clinical records and investigations, focusing on treatment response, side effects, and long‐term outcomes.Results: The prevalence of infantile spasms in Down syndrome was 3.0% during the study period. Fifty‐four infants were identified with median age of spasm onset at 201 days (interquartile range [IQR] 156–242). Spasm cessation was achieved in 88% (n=46) at a median of 110 days (IQR 5–66). The most common first‐line medications were prednisolone (n=20, 37%), vigabatrin (n=18, 33.3%), and sodium valproate (n=9, 16.7%). At follow‐up (median age 23.7mo; IQR 13.4–40.6), 25% had ongoing seizures and 85% had developmental concerns. Treatment within 60 days did not correlate with spasm cessation. Seventeen children (31%) experienced medication side effects, with vigabatrin accounting for 52%.Interpretation: Prednisolone is an effective and well‐tolerated medication for treating infantile spasms in Down syndrome. Despite the high percentage of spasm cessation, developmental concerns and ongoing seizures were common.
- 29 January 2022
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 64 (6) , 780-788
Open AccessResponse to treatment and outcomes of infantile spasms in Down syndrome
Aim: To estimate the prevalence, and evaluate presentation, treatment response, treatment side effects, and long‐term seizure outcomes in all known cases of children with Down syndrome and infantile spasms on the island of Ireland.Method: This was a 10‐year retrospective multicentre review of clinical records and investigations, focusing on treatment response, side effects, and long‐term outcomes.Results: The prevalence of infantile spasms in Down syndrome was 3.0% during the study period. Fifty‐four infants were identified with median age of spasm onset at 201 days (interquartile range [IQR] 156–242). Spasm cessation was achieved in 88% (n=46) at a median of 110 days (IQR 5–66). The most common first‐line medications were prednisolone (n=20, 37%), vigabatrin (n=18, 33.3%), and sodium valproate (n=9, 16.7%). At follow‐up (median age 23.7mo; IQR 13.4–40.6), 25% had ongoing seizures and 85% had developmental concerns. Treatment within 60 days did not correlate with spasm cessation. Seventeen children (31%) experienced medication side effects, with vigabatrin accounting for 52%.Interpretation: Prednisolone is an effective and well‐tolerated medication for treating infantile spasms in Down syndrome. Despite the high percentage of spasm cessation, developmental concerns and ongoing seizures were common.
- Open Access
- 1 June 2010
- Published by Elsevier in The Journal of Pediatrics
- Vol. 156 (6) , 1030
Traumatic Delivery, Diaphragmatic Paresis, and “Dextrocardia”
- 1 June 2010
- Published by Elsevier in The Journal of Pediatrics
- Vol. 156 (6) , 1030
Open AccessTraumatic Delivery, Diaphragmatic Paresis, and “Dextrocardia”